Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emergent Biosolutions (NY: EBS )

13.97 +0.17 (+1.23%)
Official Closing Price Updated: 7:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,585,763
Open 13.99
Bid (Size) 13.84 (1)
Ask (Size) 14.02 (1)
Prev. Close 13.80
Today's Range 13.43 - 14.27
52wk Range 1.420 - 14.61
Shares Outstanding 52,400,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
From Emergent BioSolutions
Via GlobeNewswire

Performance

YTD
+439.38%
+439.38%
1 Month
+102.76%
+102.76%
3 Month
+616.41%
+616.41%
6 Month
+651.08%
+651.08%
1 Year
+95.11%
+95.11%

More News

Read More
How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings
Via Benzinga
Key Takeaways From Emergent BioSolutions Analyst Ratings
Via Benzinga
Looking Into Emergent BioSolutions's Recent Short Interest
Via Benzinga
Watch These 4 Overbought Stocks As Market Rotation Continues
Via MarketBeat
Topics ETFs
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
Via Benzinga
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs
Via Benzinga
Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing
Via Benzinga
Exposures COVID-19
Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan
From Emergent BioSolutions
Via GlobeNewswire
Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday?
Via Benzinga
Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
From Emergent BioSolutions
Via GlobeNewswire
7 Top Stocks Under $10: June 2024 Edition
Via InvestorPlace
What Is Going On With Emergent BioSolutions Shares?
Via Benzinga
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day
From Emergent BioSolutions
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
7 Stocks to Buy Immediately Following Strong Earnings
Via InvestorPlace
Vice Stock Vanguards: 3 Sin Stocks Delivering Heavenly Returns
Via InvestorPlace
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
From Emergent BioSolutions
Via GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?
Via Benzinga
Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.